• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受合成代谢雄激素治疗患者的肝脏病变

Hepatic lesions in patients on anabolic androgenic therapy.

作者信息

Turani H, Levi J, Zevin D, Kessler E

出版信息

Isr J Med Sci. 1983 Apr;19(4):332-7.

PMID:6853130
Abstract

The histopathological changes in the livers of 11 patients treated with alkylated and nonalkylated anabolic androgenic steroids are presented. The histological changes in the liver included: proliferation of the bile ducts with or without cystic dilatation (9/11), peliosis (8/11), atypical hyperplasia of liver cells (2/11), and tumors (3/11). The latter included one case of cholangiocarcinoma, one of hepatocellular carcinoma, and one of combined cholangiocellular and hepatocellular carcinoma. The pathological changes in the liver in this series suggest a possible relationship between anabolic androgenic steroids and bile duct proliferation and/or cholangiocarcinoma.

摘要

本文呈现了11例接受烷基化和非烷基化合成代谢雄激素类固醇治疗患者肝脏的组织病理学变化。肝脏的组织学变化包括:胆管增生伴或不伴囊性扩张(9/11)、肝紫癜(8/11)、肝细胞非典型增生(2/11)以及肿瘤(3/11)。后者包括1例胆管癌、1例肝细胞癌以及1例胆管细胞和肝细胞联合癌。该系列研究中肝脏的病理变化提示合成代谢雄激素类固醇与胆管增生和/或胆管癌之间可能存在关联。

相似文献

1
Hepatic lesions in patients on anabolic androgenic therapy.接受合成代谢雄激素治疗患者的肝脏病变
Isr J Med Sci. 1983 Apr;19(4):332-7.
2
Peliosis hepatis associated with androgenic-anabolic steroid therapy. A severe form of hepatic injury.与雄激素-合成代谢类固醇治疗相关的肝紫癜。一种严重的肝损伤形式。
Ann Intern Med. 1974 Nov;81(5):610-8. doi: 10.7326/0003-4819-81-5-610.
3
Association of androgenic-anabolic steroid therapy with development of hepatocellular carcinoma.雄激素-合成代谢类固醇疗法与肝细胞癌发生的关联。
Lancet. 1972 Dec 16;2(7790):1273-6. doi: 10.1016/s0140-6736(72)92649-9.
4
[Liver lesions due to long-term use of anabolic steroids and oral contraceptives].长期使用合成代谢类固醇和口服避孕药导致的肝脏病变
Ned Tijdschr Geneeskd. 1976 Dec 11;120(50):2214-20.
5
American Academy of Pediatrics. Committee on Neoplastic Diseases. Is liver cancer induced by treating aplastic anemia with androgenic agents?美国儿科学会。肿瘤疾病委员会。用雄激素制剂治疗再生障碍性贫血会诱发肝癌吗?
Pediatrics. 1974 May;53(5):764.
6
Hepatocellular adenomas associated with anabolic androgenic steroid abuse in bodybuilders: a report of two cases and a review of the literature.与健美运动员滥用合成代谢雄激素类固醇相关的肝细胞腺瘤:两例报告及文献综述
Br J Sports Med. 2005 May;39(5):e27. doi: 10.1136/bjsm.2004.013599.
7
Toxic effects of anabolic-androgenic steroids in primary rat hepatic cell cultures.合成代谢雄激素类固醇对原代大鼠肝细胞培养物的毒性作用。
J Pharmacol Toxicol Methods. 1995 Aug;33(4):187-95. doi: 10.1016/1056-8719(94)00073-d.
8
Multiple hepatic adenomas caused by long-term administration of androgenic steroids for aplastic anemia in association with familial adenomatous polyposis.长期使用雄激素类固醇治疗再生障碍性贫血并伴有家族性腺瘤性息肉病导致的多发性肝腺瘤。
J Gastroenterol. 2000;35(7):557-62. doi: 10.1007/s005350070081.
9
Anabolic steroid therapy and intrahepatic cholangiocarcinoma.合成代谢类固醇疗法与肝内胆管癌
Cancer. 1979 Feb;43(2):440-3. doi: 10.1002/1097-0142(197902)43:2<440::aid-cncr2820430206>3.0.co;2-r.
10
Androgens and liver tumors: Fanconi's anemia and non-Fanconi's conditions.雄激素与肝脏肿瘤:范可尼贫血及非范可尼贫血相关病症
Am J Hematol. 2004 Nov;77(3):257-67. doi: 10.1002/ajh.20183.

引用本文的文献

1
Development of Liver Cancers as an Unexpected Consequence of Anabolic Androgenic Steroid Use.使用合成代谢雄激素类固醇意外导致肝癌的发生。
Cureus. 2023 Jan 29;15(1):e34357. doi: 10.7759/cureus.34357. eCollection 2023 Jan.
2
Hepatotoxicity by Dietary Supplements: A Tabular Listing and Clinical Characteristics.膳食补充剂所致肝毒性:列表及临床特征
Int J Mol Sci. 2016 Apr 9;17(4):537. doi: 10.3390/ijms17040537.
3
Pharmacokinetics of modified slow-release oral testosterone over 9 days in normal men with experimental hypogonadism.
实验性性腺功能减退的正常男性中改良缓释口服睾酮9天的药代动力学
J Androl. 2012 May-Jun;33(3):420-6. doi: 10.2164/jandrol.111.014514. Epub 2011 Aug 25.
4
Steady-state pharmacokinetics of oral testosterone undecanoate with concomitant inhibition of 5α-reductase by finasteride.口服十一酸睾酮与非那雄胺同时抑制5α-还原酶的稳态药代动力学。
Int J Androl. 2011 Dec;34(6 Pt 1):541-7. doi: 10.1111/j.1365-2605.2010.01120.x. Epub 2010 Oct 24.
5
Pharmacokinetics of 2 novel formulations of modified-release oral testosterone alone and with finasteride in normal men with experimental hypogonadism.两种新型缓释口服睾酮制剂单独及与非那雄胺联合应用于实验性性腺功能减退正常男性的药代动力学研究。
J Androl. 2010 Nov-Dec;31(6):527-35. doi: 10.2164/jandrol.109.009746. Epub 2010 Apr 8.
6
Risk factors for cholangiocarcinoma in a low risk Caucasian population.低风险白种人群中胆管癌的危险因素
Soz Praventivmed. 2001;46(3):182-5. doi: 10.1007/BF01324254.
7
Hepatocellular carcinoma associated with anabolic steroid therapy: report of a case and review of the Japanese literature.与合成代谢类固醇治疗相关的肝细胞癌:一例报告及日本文献综述
J Gastroenterol. 1996 Jun;31(3):450-4. doi: 10.1007/BF02355039.
8
Androgenic steroid effects on liver and red cells.雄激素类固醇对肝脏和红细胞的影响。
Br J Sports Med. 1985 Mar;19(1):15-20. doi: 10.1136/bjsm.19.1.15.
9
Reversal of liver damage due to long term methyltestosterone and safety of non-17 alpha-alkylated androgens.长期使用甲基睾酮所致肝损伤的逆转及非17α-烷基化雄激素的安全性
Br Med J (Clin Res Ed). 1985 Sep 7;291(6496):637. doi: 10.1136/bmj.291.6496.637.
10
Adverse effects of anabolic steroids.合成代谢类固醇的不良反应。
Med Toxicol Adverse Drug Exp. 1989 Jul-Aug;4(4):254-71. doi: 10.1007/BF03259912.